Edesa Biotech Inc (EDSA) Stock Price, Quote & News

Company Profile

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phas...

Industry: Biotechnology

Sector: Healthcare

Phone: 289 800 9600

Website: www.edesabiotech.com

Address:

100 Spy Court, Markham, Canada

TheGhostOfEd Aug. 24 at 8:36 PM

$EDSA Edesa Biotech is a Canadian shitco run by the world's most incompetent bio management team and Gary "don't throw out that watermelon". Fixed that for ya.

0 · Reply

TheGhostOfEd Aug. 23 at 10:17 PM

$EDSA Thanks for that brilliant update. Had no idea.

1 · Reply

PrivateEquityAdvisors Aug. 23 at 1:06 PM

$EDSA Edesa Biotech Inc is a clinical stage immunology company with early development programs

1 · Reply

EireTrader Aug. 22 at 7:17 PM

$EDSA

0 · Reply

Moneyybaggs Aug. 22 at 6:55 PM

$EDSA You can say that again Eddy!!! Par is a damn good scammer!!! At least he’s losing a shitload more money than me!!! Fookin moron!!!

0 · Reply

TheGhostOfEd Aug. 22 at 4:14 PM

$EDSA Just such a horrible horrible investment

0 · Reply

TheGhostOfEd Aug. 22 at 4:13 PM

$EDSA Like clockwork lol. This fucking company. So awful.

0 · Reply

TheGhostOfEd Aug. 22 at 2:58 PM

$EDSA It's coming the bid has already dropped. Written in the stars.

0 · Reply

TheGhostOfEd Aug. 22 at 2:48 PM

$EDSA Market is ripping so you know this going do be down like 8% on the close

0 · Reply

EireTrader Aug. 21 at 8:41 PM

$EDSA .. We are ripe for some positive news. Hopefully before HGW conference

2 · Reply

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

May 14, 2025, 4:15 PM EDT - 3 months ago

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Apr 28, 2025, 4:30 PM EDT - 4 months ago

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Apr 4, 2025, 4:15 PM EDT - 5 months ago

Edesa Biotech Announces Chief Financial Officer Transition

Feb 14, 2025, 4:15 PM EST - 6 months ago

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Feb 13, 2025, 7:00 AM EST - 6 months ago

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dec 13, 2024, 4:30 PM EST - 9 months ago

Edesa Biotech Reports Fiscal Year 2024 Results

Oct 31, 2024, 8:15 AM EDT - 10 months ago

Edesa Biotech's Founder Makes Strategic Investment in the Company

Oct 21, 2024, 8:15 AM EDT - 10 months ago

Edesa Biotech Announces Upcoming Conference Schedule

Sep 13, 2024, 7:38 PM EDT - 1 year ago

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.

Aug 9, 2024, 4:20 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Jun 24, 2024, 8:20 AM EDT - 1 year ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

May 10, 2024, 4:15 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

Apr 2, 2024, 9:00 AM EDT - 1 year ago

Edesa Biotech to Participate in Upcoming Investor Conferences

Mar 21, 2024, 4:30 PM EDT - 1 year ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

Mar 7, 2024, 8:45 AM EST - 1 year ago

Edesa Biotech to Participate in Barclays Global Healthcare Conference

Mar 4, 2024, 4:30 PM EST - 1 year ago

Edesa Biotech to Participate in Upcoming Dermatology Meetings

Feb 9, 2024, 4:15 PM EST - 1 year ago

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Jan 4, 2024, 4:15 PM EST - 1 year ago

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Dec 15, 2023, 4:10 PM EST - 1 year ago

Edesa Biotech Reports Fiscal Year 2023 Results

Nov 20, 2023, 4:05 PM EST - 1 year ago

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

Oct 26, 2023, 4:05 PM EDT - 1 year ago

Edesa Biotech to Present at Dermatology Drug Development Summit

Oct 25, 2023, 9:10 AM EDT - 1 year ago

Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug

Oct 12, 2023, 12:15 PM EDT - 2 years ago

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Oct 12, 2023, 12:10 PM EDT - 2 years ago

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Edesa Biotech Announces One-for-Seven Reverse Share Split

Sep 28, 2023, 8:15 AM EDT - 2 years ago

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

Aug 9, 2023, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Jul 26, 2023, 9:00 AM EDT - 2 years ago

Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Jun 28, 2023, 7:55 AM EDT - 2 years ago

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Jun 27, 2023, 8:15 AM EDT - 2 years ago

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Jun 15, 2023, 8:00 AM EDT - 2 years ago

Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name

May 11, 2023, 4:30 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

Apr 20, 2023, 8:30 AM EDT - 2 years ago

Edesa Biotech to Participate in Swiss Biotech Day

Apr 4, 2023, 8:45 AM EDT - 2 years ago

The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate

Mar 23, 2023, 4:30 PM EDT - 2 years ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference

Mar 16, 2023, 4:10 PM EDT - 2 years ago

Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting

Mar 15, 2023, 8:10 AM EDT - 2 years ago

Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

Feb 10, 2023, 9:00 AM EST - 2 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Feb 1, 2023, 8:15 AM EST - 2 years ago

Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

Jan 17, 2023, 8:30 AM EST - 2 years ago

Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug

Dec 20, 2022, 8:30 AM EST - 2 years ago

FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate

Dec 16, 2022, 9:00 AM EST - 2 years ago

Edesa Biotech Reports Fiscal Year 2022 Results

Dec 2, 2022, 8:00 AM EST - 2 years ago

Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference

Nov 3, 2022, 9:00 AM EDT - 3 years ago

Edesa Biotech Announces Closing of $3.0 Million Private Placement Priced At-the-Market

Sep 30, 2022, 8:00 AM EDT - 3 years ago

Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study

Sep 8, 2022, 4:30 PM EDT - 3 years ago

Edesa Biotech to Present at Upcoming H.C. Wainwright Investor Conference

Sep 7, 2022, 8:00 AM EDT - 3 years ago

Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment

Aug 12, 2022, 4:30 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal 3rd Quarter 2022 Results

Aug 3, 2022, 8:15 AM EDT - 3 years ago

Edesa Biotech to Participate at the Upcoming BTIG Biotech Conference

TheGhostOfEd Aug. 24 at 8:36 PM

$EDSA Edesa Biotech is a Canadian shitco run by the world's most incompetent bio management team and Gary "don't throw out that watermelon". Fixed that for ya.

0 · Reply

TheGhostOfEd Aug. 23 at 10:17 PM

$EDSA Thanks for that brilliant update. Had no idea.

1 · Reply

PrivateEquityAdvisors Aug. 23 at 1:06 PM

$EDSA Edesa Biotech Inc is a clinical stage immunology company with early development programs

1 · Reply

EireTrader Aug. 22 at 7:17 PM

$EDSA

0 · Reply

Moneyybaggs Aug. 22 at 6:55 PM

$EDSA You can say that again Eddy!!! Par is a damn good scammer!!! At least he’s losing a shitload more money than me!!! Fookin moron!!!

0 · Reply

TheGhostOfEd Aug. 22 at 4:14 PM

$EDSA Just such a horrible horrible investment

0 · Reply

TheGhostOfEd Aug. 22 at 4:13 PM

$EDSA Like clockwork lol. This fucking company. So awful.

0 · Reply

TheGhostOfEd Aug. 22 at 2:58 PM

$EDSA It's coming the bid has already dropped. Written in the stars.

0 · Reply

TheGhostOfEd Aug. 22 at 2:48 PM

$EDSA Market is ripping so you know this going do be down like 8% on the close

0 · Reply

EireTrader Aug. 21 at 8:41 PM

$EDSA .. We are ripe for some positive news. Hopefully before HGW conference

2 · Reply

pausiloy Aug. 21 at 1:23 PM

$EDSA lets strong hold together, we only need 1% up every day, slowly sp will climb to $100 after 386 trading days

0 · Reply

Moneyybaggs Aug. 21 at 11:52 AM

$EDSA Something has got to give. The SP has been languishing between $2-2.40 for what seems like an eternity. Either this pig starts moving up or crashes to $1. How it’s not at $1 now with no news in two years is mystifying to me. Par, may the fleas of 10K filthy camels infest your pits and groin!!! FMTT!!!

2 · Reply

TheGhostOfEd Aug. 20 at 9:05 PM

$EDSA I don't love the "golden cross" as it's very laggy and noisy signal but tomorrow we should see that happens, 50 crossing the 200....a few of the indicators are swaying bullish. Would love to see some news to top it off.

0 · Reply

TheGhostOfEd Aug. 20 at 8:27 PM

$EDSA Gonna need to see more robust site activation by PPF if we hope to see the BARDA trial complete anywhere close to ontime.

0 · Reply

TheGhostOfEd Aug. 20 at 2:52 PM

$EDSA https://x.com/unusual_whales/status/1958126114116976915?s=46 I thought Edesa was solving this with the 40 internships they never created for a grant they never used 😂😂😂😂

0 · Reply

Moneyybaggs Aug. 20 at 1:19 PM

$EDSA Gotta love HBC’s manipulation!!!! MAYBE one of these days TURDESA will be up $.23 PM on 70K shares traded versus 7. FMTT!!!

0 · Reply

TheGhostOfEd Aug. 19 at 8:10 PM

$EDSA Always a disappointment

1 · Reply

TheGhostOfEd Aug. 19 at 5:36 PM

$EDSA the whale is back

0 · Reply

TheGhostOfEd Aug. 19 at 3:49 PM

$EDSA 2.44 is 50 period weekly moving average functioning as big resistance (for now). Funny enough we have not meaningfully traded above that level since late 2021. Really puts into context what a downward spiral this has been.

0 · Reply

TheGhostOfEd Aug. 19 at 2:10 PM

$EDSA 3 more sites added on CT page, but one site withdrawn (reno nv)

0 · Reply

AllPenniesNoDividends Aug. 18 at 11:57 PM

$EDSA Something needs to happen sooner or later…. ⏰⏰⏰

1 · Reply

Moneyybaggs Aug. 18 at 5:09 PM

$EDSA Looks like I nailed that one!!! It’s always fun to dream though.

0 · Reply

Market Cap	16.89M
Revenue (ttm)	0.00
Net Income (ttm)	-6.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	30,300
Avg Vol	25,078
Day's Range	N/A - N/A
Shares Out	7.04M
Stochastic %K	77%
Beta	0.27
Analysts	Strong Sell
Price Target	$11.00